Literature DB >> 22426780

Perturbation of glycerol metabolism in hepatocytes from n3-PUFA-depleted rats.

Laurence Portois1, Ying Zhang, Laurence Ladrière, Jason Perret, Karim Louchami, Nathalie Gaspard, Emeline Hupkens, Nargis Bolaky, Valérie Delforge, Renaud Beauwens, Willy J Malaisse, Abdullah Sener, Yvon A Carpentier, Christine Delporte.   

Abstract

Second generation n3-PUFA-depleted rats represent a good animal model of metabolic syndrome as they display several features of the disease such as liver steatosis, visceral obesity and insulin resistance. The goal of our study was to investigate the influence of n3-PUFA deficiency on hepatic glycerol metabolism. Aquaglyceroporin 9 (AQP9) allows hepatic glycerol transport and consequently contributes to neoglucogenesis. AQP9 knockout mice display hypertriacyl-glycerolemia, one of the hallmarks of the metabolic syndrome. Our data show reduced AQP9 expression at the protein level in n3-PUFA-depleted rats, without any changes at the mRNA levels. [U-¹⁴C]glycerol uptake was increased in hepatocytes from n3-PUFA-depleted animal cells. The apparent discrepancy between decreased AQP9 protein expression, and increased [U-¹⁴C]glycerol uptake could be explained by an observed increase in glycerol kinase activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426780     DOI: 10.3892/ijmm.2012.943

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

1.  Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease.

Authors:  Patrizia Gena; Maria Mastrodonato; Piero Portincasa; Elena Fanelli; Donatella Mentino; Amaia Rodríguez; Raúl A Marinelli; Catherine Brenner; Gema Frühbeck; Maria Svelto; Giuseppe Calamita
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

2.  Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome.

Authors:  Nishika Sahini; Saravanakumar Selvaraj; Jürgen Borlak
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

Review 3.  Hepatocyte and Sertoli Cell Aquaporins, Recent Advances and Research Trends.

Authors:  Raquel L Bernardino; Raul A Marinelli; Anna Maggio; Patrizia Gena; Ilaria Cataldo; Marco G Alves; Maria Svelto; Pedro F Oliveira; Giuseppe Calamita
Journal:  Int J Mol Sci       Date:  2016-07-09       Impact factor: 5.923

Review 4.  Aquaporins in insulin resistance and diabetes: More than channels!

Authors:  Mauro Galli; Ahsan Hameed; Arkadiusz Żbikowski; Piotr Zabielski
Journal:  Redox Biol       Date:  2021-05-27       Impact factor: 11.799

Review 5.  Sexual Dimorphism of Adipose and Hepatic Aquaglyceroporins in Health and Metabolic Disorders.

Authors:  Amaia Rodríguez; Raul A Marinelli; Angela Tesse; Gema Frühbeck; Giuseppe Calamita
Journal:  Front Endocrinol (Lausanne)       Date:  2015-11-05       Impact factor: 5.555

Review 6.  Aquaglyceroporins: Drug Targets for Metabolic Diseases?

Authors:  Giuseppe Calamita; Jason Perret; Christine Delporte
Journal:  Front Physiol       Date:  2018-07-10       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.